Heath-Chiozzi Margo has filed 15 insider transactions across 1 company since June 2023.
Most recent transaction: a grant/award of 82000 shares of Celldex Therapeutics, Inc. ($CLDX) on June 05, 2025.
Activity breakdown: 0 open-market purchases and 2 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| June 5, 2025 | Celldex Therapeutics, Inc. | $CLDX | Heath-Chiozzi Margo | SVP OF REGULATORY AFFAIRS | A | Incentive Stock Option (right to buy) | 82000 | $0.00 | 82,000.0000 | 66,383 | 9999.99% | 100.00% |
| June 13, 2024 | Celldex Therapeutics, Inc. | $CLDX | Heath-Chiozzi Margo | SVP OF REGULATORY AFFAIRS | A | Incentive Stock Option (right to buy) | 82000 | $0.00 | 82,000.0000 | 58,871 | 9999.99% | 100.00% |
| June 3, 2024 | Celldex Therapeutics, Inc. | $CLDX | Heath-Chiozzi Margo | SVP OF REGULATORY AFFAIRS | M | Common Stock | 6289 | $9.02 | 13,383.0000 | 58,871 | 88.65% | 10.68% |
| June 3, 2024 | Celldex Therapeutics, Inc. | $CLDX | Heath-Chiozzi Margo | SVP OF REGULATORY AFFAIRS | M | Common Stock | 58369 | $10.38 | 71,752.0000 | 58,871 | 436.14% | 99.15% |
| June 3, 2024 | Celldex Therapeutics, Inc. | $CLDX | Heath-Chiozzi Margo | SVP OF REGULATORY AFFAIRS | S | Common Stock | 58369 | $33.65 | 13,383.0000 | 58,871 | 81.35% | 99.15% |
| June 3, 2024 | Celldex Therapeutics, Inc. | $CLDX | Heath-Chiozzi Margo | SVP OF REGULATORY AFFAIRS | M | Incentive Stock Option (Right to Buy) | 6289 | $0.00 | 0.0000 | 58,871 | 100.00% | 10.68% |
| June 3, 2024 | Celldex Therapeutics, Inc. | $CLDX | Heath-Chiozzi Margo | SVP OF REGULATORY AFFAIRS | M | Incentive Stock Option (Right to Buy) | 58369 | $0.00 | 23,023.0000 | 58,871 | 71.71% | 99.15% |
| May 30, 2024 | Celldex Therapeutics, Inc. | $CLDX | Heath-Chiozzi Margo | SVP OF REGULATORY AFFAIRS | M | Common Stock | 29068 | $2.78 | 41,162.0000 | 58,871 | 240.35% | 49.38% |
| May 30, 2024 | Celldex Therapeutics, Inc. | $CLDX | Heath-Chiozzi Margo | SVP OF REGULATORY AFFAIRS | M | Common Stock | 2043 | $9.02 | 43,205.0000 | 58,871 | 4.96% | 3.47% |
| May 30, 2024 | Celldex Therapeutics, Inc. | $CLDX | Heath-Chiozzi Margo | SVP OF REGULATORY AFFAIRS | M | Common Stock | 2608 | $10.38 | 45,813.0000 | 58,871 | 6.04% | 4.43% |
| May 30, 2024 | Celldex Therapeutics, Inc. | $CLDX | Heath-Chiozzi Margo | SVP OF REGULATORY AFFAIRS | S | Common Stock | 38719 | $34.07 | 7,094.0000 | 58,871 | 84.52% | 65.77% |
| May 30, 2024 | Celldex Therapeutics, Inc. | $CLDX | Heath-Chiozzi Margo | SVP OF REGULATORY AFFAIRS | M | Incentive Stock Option (Right to Buy) | 29068 | $0.00 | 12,732.0000 | 58,871 | 69.54% | 49.38% |
| May 30, 2024 | Celldex Therapeutics, Inc. | $CLDX | Heath-Chiozzi Margo | SVP OF REGULATORY AFFAIRS | M | Incentive Stock Option (Right to Buy) | 2043 | $0.00 | 6,289.0000 | 58,871 | 24.52% | 3.47% |
| May 30, 2024 | Celldex Therapeutics, Inc. | $CLDX | Heath-Chiozzi Margo | SVP OF REGULATORY AFFAIRS | M | Incentive Stock Option (Right to Buy) | 2608 | $0.00 | 81,392.0000 | 58,871 | 3.10% | 4.43% |
| June 15, 2023 | Celldex Therapeutics, Inc. | $CLDX | Heath-Chiozzi Margo | SVP OF REGULATORY AFFAIRS | A | Incentive Stock Option (right to buy) | 80000 | $0.00 | 80,000.0000 | 47,214 | 9999.99% | 100.00% |